Aspergillosi polmonare, leucemie e trapianti

Translated title of the contribution: Pulmonary aspergillosis, leukemia and organ transplants

G. Agolini, M. Andolina, F. Biffoni, E. Generali, N. Maximova, M. Rabusin

Research output: Contribution to journalArticlepeer-review

Abstract

The progress in treatment of leukaemia and in prevention of reject of transplanted organs caused an increase in pulmonary aspergillosis, as an often lethal complication in immunodepressed patients. Aspergillus spores, suspended in the air, can be easily inhaled: environmental disinfectants have not be used in wards, even for frequent nebulization. Nosocomial aspergillosis prevention have to be based on patients cohorting in departments where an efficient HEPA filtering system avoid dirt and dust contamination of the air and stop the airborne Aspergillus conidia diffusion. The availability of more efficient antimycotic drugs is a prerequisite for a better prevention.

Translated title of the contributionPulmonary aspergillosis, leukemia and organ transplants
Original languageItalian
Pages (from-to)137-142
Number of pages6
JournalTrasfusione del Sangue
Volume42
Issue number3
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Hematology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Pulmonary aspergillosis, leukemia and organ transplants'. Together they form a unique fingerprint.

Cite this